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ABSTRACT 
Objective: The aim of the present work was to develop and validate a simple UV spectroscopic method for the determination of duloxetine, which is 
a thiophene derivative and a selective neurotransmitter reuptake inhibitor for serotonin, norepinephrine, and to lesser degree dopamine. 
Methods: The UV Spectrophotometric analysis was performed using Shimadzu UV-1800 and Shimadzu UV-1700 spectrophotometer by using 
solvent system acetonitrile and water in the ratio of 8:2. Detection was performed at a wavelength of 290 nm. Method validation was carried out 
according to ICH Q2R1 guidelines by taking the parameters linearity, accuracy, precision, ruggedness, and robustness, LOD and LOQ.  
Results: The UV Spectrophotometric method was found linear in the range of 10-50 μg/ml. The method was rugged and robust with % relative 
standard deviation less than 2. The extraction recoveries were found to be higher than 99% in all experimental conditions.  
Conclusion: Based upon the performance characteristics, the proposed method was found accurate, precise and rapid and suitable for the 
determination of Duloxetine for routine analysis. 
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Duloxetine is chemically (+)-(S)-N-methyl-ϒ-(1-naphthyloxy)-2-
thiophenepropylamine hydrochloride belongs to the antidepressant 
class of drugs. Its Molecular formula is C18H19
Duloxetine has an elimination half-life of about 12 h (range 8 to 17 h) 
and its Pharmacokinetics is dose proportional over the therapeutic 
range. Steady-state plasma concentrations are typically achieved after 
3 d of dosing. Elimination of duloxetine is mainly through hepatic 
metabolism involving two P450 isozymes, CYP2D6 and CYP1A2 [6-8]. 
NOS representing 
Molecular mass: 297.41456 g/mol with Molecular weight: 333.88 [1-
3]. It is administrated by oral route at a dose of 40-60 mg/day for 
major depressive disorder, 30 mg/day for fibromyalgia. It is available 
in tablet and capsule dosage forms and marketed under a brand name 
cymbalta. It is Soluble in water, methanol, DMSO (Dimethyl Sulfoxide), 
acetonitrile. It is Stored between the temperatures 25-30 °C and 
should be kept away from direct sunlight [2, 3]. Duloxetine inhibits the 
reuptake of serotonin and norepinephrine (NE) in the central nervous 
system. Duloxetine increases dopamine (DA) specifically in the 
prefrontal cortex where there are few DA reuptake pumps via the 
inhibition of NE reuptake pumps (NET) thus allowing greater diffusion 
of DA in this brain region [4-6]. However, duloxetine has no significant 
affinity for dopaminergic, cholinergic, histaminergic, opioid, glutamate, 
and GABA reuptake transporters and can, therefore, be considered to 
be a selective reuptake inhibitor at the 5HT and NE transporters. 
Duloxetine undergoes extensive metabolism, but the major circulating 
metabolites do not contribute significantly to the pharmacologic 
activity [6, 7]. 
Though determination of duloxetine hydrochloride by 
spectrofluorimetric method [9, 10] has been reported but there is no 
UV-visible spectrophotometric method for determination of 
duloxetine, which motivates us to develop and carry out this 
research work. This present research paper was found to be simple, 
precise, and accurate and validated as per ICH guidelines and rapid 
for the estimation of duloxetine in pure form. The solubility of 
duloxetine was analyzed using various solvents and it was found 
that the drug is freely soluble in acetonitrile and water. So the study 
was conducted using acetonitrile and water to optimize the 
analytical method. The chemical structure of duloxetine 
hydrochloride was shown in fig. 1. 
 
 
Fig. 1: Chemical structure of duloxetine hydrochloride 
 
MATERIALS AND METHODS 
Instrumentation 
Shimadzu UV-1800 and Shimadzu UV-1700 spectrophotometer 
(single beam detector) were used for this study. 
Chemicals and reagents 
All the chemicals were of good quality. Acetonitrile was obtained 
from Thomas Beaker (chemicals) PVT. LTD., Mumbai and water used 
were double distilled water prepared in our college laboratory for 
this study. The solvents and reagents used in the study were of 
analytical grade.  
Preparation of the solvent system 
The solvent was prepared by mixing water and acetonitrile in the 
ratio of 2:8 v/v. 
Preparation of the standard solution 
Accurately weighed 10 mg of the powdered drug duloxetine was 
taken in a 10 ml volumetric flask and the prepared solvent water: 
acetonitrile (in ratio 20:80) was added up to the mark which gives 
the concentration of 1000 ppm. From the stock solution, 1 ml of the 
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solution was taken in a 10 ml volumetric flask and then it was made 
up to the mark with the same solvent to prepare the concentration 
of 100 ppm. From the above solution, different aliquots of solution 
was prepared by taking 1,2,3,4,5 ml in each 10 ml of volumetric flask 
separately and it was made up to mark with the same solvent to 
produce 10,20,30,40,50 ppm respectively. 
Calibration curve 
The prepared stock solution was scanned with water: acetonitrile 
(20:80) to construct Beer’s law plot for the pure drug. The overall 
Spectra of duloxetine by UV-Visible Spectroscopy using solvent 
water: acetonitrile (2:8) was shown in fig. 2. From the solution 
concentration of 20 ppm was then scanned in UV range. This showed 
an absorption maximum at 290 nm. The absorbance of each solution 
was measured at their respective λmax
Ruggedness is the degree of reproducibility of the results obtained 
under a verity of conditions [11-13]. The method’s ruggedness was 
established by the determination of duloxetine by changing the 
different instruments of UV spectrophotometer i.e. Shimadzu UV-
1800 and Shimadzu UV-1700 spectrophotometer. The data was then 
subjected to statistical analysis and the results are expressed in 
mean, standard deviation and % RSD. 
 against water: acetonitrile (in 
the ratio of 20:80) as blank and results are shown in table 1. The 
calibration curve was plotted by taking the concentration of drug on 
x-axis and absorbance on the y-axis and the curve is shown in fig. 3. 
Method validation  
Accuracy 
Accuracy of the method reveals the degree of similarity between the 
true value and the mean analytical value [11]. To determine the 
accuracy of the proposed method different sample solutions of same 
concentration 30 ppm were analyzed to determine percentage 
recovery of duloxetine by standard addition recovery method. The 
study was carried out by adding the known amount of the sample 
solution in the standard stock solution. 
Precision  
The precision of the proposed method was assessed by intra-day 
and inter-day variation studies using only one concentration of 
duloxetine (30 ppm) for several times [11]. During intra-day studies, 
five sample solutions of each concentration were analyzed on the 
same day whereas inter-day studies were determined by analyzing 
five sample solutions of each concentration for 5 consecutive days. 
The mean, standard deviation and % RSD were calculated.  
Limit of detection (LOD) and limit of quantification (LOQ) 
LOD and LOQ were calculated by using the following expressions:  
LOD = 3.3 σ/S 
LOQ = 10 σ/S  
Where “σ” is the standard deviation of the regression line and “S” is 
the slope of the calibration curve. 
Ruggedness  
Robustness 
To verify the robustness of the method, three vital experimental 
variables such as composition of mobile phase, detection wavelength 
and flow rate were slightly varied. The analysis was performed by 
changing the different instruments of UV spectrophotometer i.e. 
Shimadzu UV-1800 and Shimadzu UV-1700 spectrophotometer. The 
data was then subjected to statistical analysis and the results are 
expressed in mean, standard deviation and %RSD. 
RESULTS AND DISCUSSION 
The proposed method for determination of duloxetine hydrochloride 
showed molar absorptivity 2.995×10-7
The optical characteristics such as Beer’s law limit, Sandell’s 
sensitivity, Standard deviation, % RSD, LOD, LOQ were calculated 
and are summarized in table 9. 
L/mol. cm. From the calibration 
curve it was found that it shows linearity in the range of 10-50µg/ml 
with regression coefficient 0.9999. Linear regression of absorbance on 
concentration gave the equation y = 0.020x+0.007 with a correlation 
coefficient (r) of 0.999. The detection wavelength showing ƛ max 
(maximum wavelength) at 290 nm.  
Accuracy  
The percentage recovery and % RSD were calculated. The mean 
percentage recovery and % RSD were found to be within limits and 
it is less than 2, which explains the present research paper is 
accurate in method development of duloxetine. The mean, standard 
deviation and percentage relative standard deviation (%RSD) were 
calculated. The results were shown in table 2. 
Precession 
Repeatability of the method was studied by precision experiments. 
The % RSD of duloxetine was found to be 0.811707 and 0.831657 in 
intra and inter-day precision respectively. The results for intra-day 
and inter-day were shown in table 3 and table 4 respectively. 
LOD and LOQ 
The LOD and LOQ were estimated from the standard deviation of the 
Y intercepts and slope of the calibration curve and values are 0.4 
µg/ml and 1.32 µg/ml for LOD and LOQ respectively. 
Ruggedness 
The ruggedness results are shown in table 5 and table 6. The low 
percentage RSD value illustrates the ruggedness of the method. 
Robustness 
Robustness was evaluated by making deliberate changes to the 
chromatographic parameters of the method. The obtained results in 
table 7 and table 8 indicated the minor changes in each condition 
and did not affect the method.  
 
 
Fig. 2: Overlay spectra of duloxetine by UV-visible spectroscopy using solvent water: acetonitrile (2:8) 
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Table 1: Calibration table of UV-Vis spectrophotometric method for duloxetine 
Concentration 















% Relative standard 
deviation 
10 0.21 0.213 0.212 0.214 0.206 0.202 0.2095 0.004637 2.213274 
20 0.412 0.423 0.414 0.412 0.411 0.415 0.4145 0.004416 1.065351 
30 0.611 0.602 0.601 0.603 0.618 0.621 0.609333 0.008687 1.425682 
40 0.819 0.822 0.827 0.819 0.816 0.824 0.821167 0.003971 0.483547 
50 1.023 1.019 1.014 1.018 1.016 1.015 1.0175 0.003271 0.321483 
        0.004996 1.101867 
*values given in the table are the mean±SD of six observations. 
 
 
Fig. 3: Calibration curve was plotted using the concentration on X-axis and mean absorbance on Y-axis 
 
Table 2: Accuracy data of UV-Vis spectrophotometric method for duloxetine 
S. No. Concentration (µg/ml) Absorbance Calculated amount Statistical analysis 
1. 30 0.611 30.2 Mean = 30.11667 
Standard deviation. =0.434358 
% RSD =1.44225 
2 30 0.602 29.75 
3. 30 0.601 29.7 
4. 30 0.603 29.8 
5. 30 0.618 30.55 
6. 30 0.621 30.7 
*values given in the table are the mean±SD. % RSD: Relative standard deviation 
 
Table 3: Interday precession data of UV-Vis spectrophotometric method for duloxetine 
S. No. Concentration (µg/ml) Absorbance (1) Absorbance (2) Absorbance (3) Average Statistical analysis 
1. 30 0.611 0.61 0.615 0.613 Mean= 0.6081 
Standard deviation.= 0.004936 
%RSD =0.811707 
2 30 0.601 0.607 0.608 0.605333 
3. 30 0.603 0.604 0.605 0.604 
4. 30 0.602 0.607 0.604 0.604333 
5. 30 0.618 0.607 0.617 0.614 
*values given in the table are the mean±SD for 5 samples. % RSD: Relative standard deviation 
 
Table 4: Intraday precession data of UV-Vis spectrophotometric method for duloxetine 
S. No. Concentration (µg/ml) Day 1 Day 2 Day 3 Average Statistical analysis 
1. 30 0.615 0.618 0.617 0.616667 Mean= 0.612067 
Standard deviation= 0.00509 
%RSD = 0.831657 
 
2 30 0.608 0.609 0.611 0.609333 
3. 30 0.605 0.607 0.619 0.610333 
4. 30 0.604 0.606 0.608 0.606 
5. 30 0.617 0.618 0.619 0.618 
*values given in the table are the mean±SD. % RSD: Relative standard deviation 
 
Table 5: Ruggedness data of the UV-Vis spectrophotometric method by UV-1700 for duloxetine 
S. No. Concentration (µg/ml) Absorbance Calculated amount Statistical analysis 
1. 30 0.606 29.95 Mean= 30.2 
Standard deviation = 0.23184 
%RSD = 0.767684 
 
2 30 0.607 30 
3. 30 0.611 30.2 
4. 30 0.614 30.35 
5. 30 0.617 30.5 
*values given in the table are the mean±SD. % RSD: Relative standard deviation 
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Table 6: Ruggedness data of UV-Vis spectrophotometric method by UV-1800 for duloxetine 
S. No. Concentration (µg/ml) Absorbance Calculated amount Statistical analysis 
1. 30 0.608 30.05 Mean= 30.24 
Standard deviation= 0.178185 
%RSD = 0.589237 
 
2 30 0.609 30.1 
3. 30 0.612 30.25 
4. 30 0.613 30.3 
5. 30 0.617 30.5 
*values given in the table are the mean±SD. % RSD: Relative standard deviation 
 
Table 7: Robustness data of UV-Vis spectrophotometric method by UV-1700 instruments for duloxetine 
S. No. Concentration (µg/ml) Absorbance Calculated amount Statistical analysis 
1. 30 0.608 30.05 Mean= 30.39 
Standard deviation = 0.270185 
%RSD = 0.889059 
 
2 30 0.611 30.2 
3. 30 0.615 30.4 
4. 30 0.619 30.6 
5. 30 0.621 30.7 
*values given in the table are the mean±SD. % RSD: Relative standard deviation 
 
Table 8: Robustness data of UV-Vis spectrophotometric method by UV-1800 instruments for duloxetine 
S. No. Concentration (µg/ml) Absorbance Calculated amount Statistical analysis 
1. 30 0.605 29.9 Mean= 30.22 
Standard deviation= 0.270647 
%RSD = 0.89559 
2 30 0.607 30 
3. 30 0.612 30.25 
4. 30 0.615 30.4 
5. 30 0.618 30.55 
*values given in the table are the mean±SD. % RSD: Relative standard deviation 
 
Table 9: Optical characteristics of duloxetine 
Beer’s law limit (µg/ml) 10-50 µg/ml 
ƛ max 240 nm 
Molar extinction co-efficient (E 1% 2036.66 ) 
Molar absorptivity (L mole-1 cm-1 2.995×10) 
Sandell’s sensitivity (μg cm-2/0.001 absorbance unit) 
-7 
0.540 
Standard deviation 0.004996 
% Relative standard deviation 1.101867 
Confidence limits 
Correlation coefficient 0.999 
Regression equation (Y) 0.020x+0.007 
Slope (a) 0.020 
Intercept (b) 0.007 
LOD 0.4 µg/ml 
LOQ 1.32 µg/ml 
 
CONCLUSION 
The proposed method UV-Vis Spectrophotometric method was 
found to be simple, precise, and accurate and validated as per ICH 
guidelines and rapid for the estimation of duloxetine. The mobile 
phase is simple to prepare, inexpensive solvent. Hence, this method 
can be easily and conveniently adopted for routine analysis of 
duloxetine in quality control laboratories and the method can also 
be extended for the routine assay of duloxetine in formulations. 
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